Short Communication
Cannabis and other illicit drug use in epilepsy patients
Article first published online: 11 JAN 2013
DOI: 10.1111/ene.12081
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS
Issue

European Journal of Neurology
Early View (Online Version of Record published before inclusion in an issue)
Additional Information
How to Cite
Hamerle, M., Ghaeni, L., Kowski, A., Weissinger, F. and Holtkamp, M. (2013), Cannabis and other illicit drug use in epilepsy patients. European Journal of Neurology. doi: 10.1111/ene.12081
Publication History
- Article first published online: 11 JAN 2013
- Manuscript Accepted: 21 NOV 2012
- Manuscript Received: 10 SEP 2012
- Abstract
- Article
- References
- Cited By
Keywords:
- amphetamines;
- cocaine;
- epidemiology;
- epilepsy;
- epileptic seizures;
- illicit drugs;
- marijuana
Background and purpose
This study aimed to assess the prevalence of illicit drug use among epilepsy patients and its effects on the disease.
Methods
We systematically interviewed epilepsy outpatients at a tertiary epilepsy clinic. Predictors for active cannabis use were analysed with a logistic regression model.
Results
Overall, 310 subjects were enrolled; 63 (20.3%) reported consuming cannabis after epilepsy was diagnosed, and 16 (5.2%) used other illicit drugs. Active cannabis use was predicted by sex (male) [odds ratio (OR) 5.342, 95% confidence interval (95% CI) 1.416–20.153] and age (OR 0.956, 95% CI 0.919–0.994). Cannabis consumption mostly did not affect epilepsy (84.1%). Seizure worsening was observed with frequent illicit (non-cannabis) drug use in 80% of cases.
Conclusions
Cannabis use does not seem to affect epilepsy; however, frequent use of other drugs increases seizure risk.

1468-1331/asset/olbannerleft.jpg?v=1&s=5d3a3e0b13870c31eb751e2f9ac484568b81fd0e)